» Articles » PMID: 11856743

Activation of the C-Jun N-terminal Kinase (JNK) Signaling Pathway is Essential During PBOX-6-induced Apoptosis in Chronic Myelogenous Leukemia (CML) Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Feb 22
PMID 11856743
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The mitogen-activated protein (MAP) kinase family is activated in response to a wide variety of external stress signals such as UV irradiation, heat shock, and many chemotherapeutic drugs and leads to the induction of apoptosis. A novel series of pyrrolo-1,5-benzoxazepines have been shown to potently induce apoptosis in chronic myelogenous leukemia (CML) cells, which are resistant to many chemotherapeutic agents. In this study we have delineated part of the mechanism by which a representative compound known as PBOX-6 induces apoptosis. We have investigated whether PBOX-6 induces activation of MAP kinase signaling pathways in CML cells. Treatment of K562 cells with PBOX-6 resulted in the transient activation of two JNK isoforms, JNK1 and JNK2. In contrast, PBOX-6 did not activate the extracellular signal-regulated kinase (ERK) or p38. Apoptosis was found to occur independently of the small GTPases Ras, Rac, and Cdc42 but involved phosphorylation of the JNK substrates, c-Jun and ATF-2. Pretreatment of K562 cells with the JNK inhibitor, dicoumarol, abolished PBOX-6-induced phosphorylation of c-Jun and ATF-2 and inhibited the induced apoptosis, suggesting that JNK activation is an essential component of the apoptotic pathway induced by PBOX-6. Consistent with this finding, transfection of K562 cells with the JNK scaffold protein, JIP-1, inhibited JNK activity and apoptosis induced by PBOX-6. JIP-1 specifically scaffolds JNK, MKK7, and members of the mixed-lineage kinase (MLK) family, implicating these kinases upstream of JNK in the apoptotic pathway induced by PBOX-6 in K562 cells.

Citing Articles

Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases.

Singh A, Upadhayay S, Mehan S Neurotox Res. 2021; 39(5):1630-1650.

PMID: 34432262 DOI: 10.1007/s12640-021-00401-6.


Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK/ERK mediated apoptotic pathways.

Sun S, Zhu L, Lai M, Cheng R, Ge Y Braz J Med Biol Res. 2021; 54(8):e10685.

PMID: 34037092 PMC: 8148979. DOI: 10.1590/1414-431X2020e10685.


miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.

Dey S, Kwon J, Liu S, Hodge G, Taleb S, Zimmers T Mol Cancer Res. 2019; 18(2):311-323.

PMID: 31662451 PMC: 7002266. DOI: 10.1158/1541-7786.MCR-19-0594.


Pre-clinical evaluation of a novel class of anti-cancer agents, the Pyrrolo-1, 5-benzoxazepines.

Greene L, Butini S, Campiani G, Williams D, Zisterer D J Cancer. 2016; 7(15):2367-2377.

PMID: 27994676 PMC: 5166549. DOI: 10.7150/jca.16616.


Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine-induced apoptosis in neuroblastoma cells.

Lennon J, Butini S, Campiani G, OMeara A, Williams D, Zisterer D Invest New Drugs. 2016; 34(5):663-76.

PMID: 27334143 DOI: 10.1007/s10637-016-0366-3.